Company
NEXUS BIOPHARMA INC (0001424151)
Standardized SEC financial data for NEXUS BIOPHARMA INC — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001424151 · Pharmaceutical Preparations.
Return on equity
47.2%
Free cash flow
-$492K
Current ratio
0.00×
Income statement
| USD | FY2017 |
|---|---|
| R&D expense | $31K |
| SG&A expense | $624K |
| Net income | -$686K |
Standardized from NEXUS BIOPHARMA INC's SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2017 |
|---|---|
| Cash & equivalents | $77 |
| Total current assets | $1K |
| Property, plant & equipment | $2K |
| Total assets | $10K |
| Total current liabilities | $1.4M |
| Total liabilities |
Cash flow
| USD | FY2017 |
|---|---|
| Operating cash flow | -$492K |
| Investing cash flow | -$10K |
| Financing cash flow | $493K |
| Dividends paid | $0 |
Get 0001424151 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001424151/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001424151/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"